Patent · US Active

Inhibtors of Raf kinases

US11814384B2 · kind B2 · utility

0Cited by
2References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2023
Grant dateNov 14, 2023
Priority date—
Expiry dateFeb 3, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.